<DOC>
	<DOCNO>NCT00170287</DOCNO>
	<brief_summary>The present standard care management unstable ventricular tachycardia ( VT ) set chronic coronary artery disease placement implantable cardioverter defibrillator ( ICD ) initial episode , radiofrequency ablation and/or antiarrhythmic medication event recurrence cause frequent ICD intervention . The primary purpose randomize study assessment recurrence unstable VT patient undergo ICD implantation plus substrate ablation initial episode compare patient undergo ICD implantation . Thus primary purpose improvement quality life . A decrease mortality primary purpose study .</brief_summary>
	<brief_title>SMS : Substrate Modification Study Patients Getting Implantable Cardioverter Defibrillator ( ICD )</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Coronary artery disease document coronary angiography . For purpose study , coronary artery disease define presence 50 % diameter stenosis leave main 75 % diameter stenosis leave anterior descending , circumflex right coronary artery , history surgical percutaneous revascularization procedure . Left ventricular ejection fraction &lt; 40 % estimate echocardiography contrast ventriculography within previous 30 day . Clinical unstable VT without reversible factor ( acute ischemia antiarrhythmic medication define ) . Unstable VT one follow clinical presentation : Hypotensive VT without major neurologic dysfunction ; Syncope ; Cardiac arrest . Age &lt; 18 year &gt; 80 year Protruding leave ventricular ( LV ) thrombus preablation echocardiogram Acute myocardial infarction within precede 2 month Class IV New York Heart Association ( NYHA ) heart failure Valvular heart disease mechanical heart valve preclude access leave ventricle Unstable angina Cardiac surgery within past 2 month Serum creatinine &gt; 220 mmol/L ( 2.5 mg/dL ) Thrombocytopenia coagulopathy Contraindication heparin Pregnancy Acute illness active systemic infection Other disease process likely limit survival le 12 month Significant medical problem , opinion principal investigator , would preclude enrollment study Participation another investigational study Unwillingness participate lack availability followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Unstable Ventricular Tachycardia</keyword>
</DOC>